相关实验视频
Updated: May 9, 2025

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.4K
胆汁酸在免疫介导的皮肤疾病中的作用
Huike Ma1, Ruonan Li1, Baoquan Qu1
1Beijing Hospital of Traditional Chinese Medicine, Beijing Institute of Chinese Medicine, Capital Medical University, Beijing, China.
Experimental dermatology
|April 30, 2025
概括
胆酸干扰与免疫介导的皮肤疾病,如牛皮和亚托邦性皮肤炎有关. 准胆汁酸通路为这些炎症性皮肤疾病提供了一个有前途的新治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 代谢医学是一种代谢医学.
背景情况:
- 免疫介导的皮肤疾病会引起炎症并降低生活质量.
- 它们的发病包括遗传学,环境和免疫激活.
- 胆酸干扰越来越多地与皮肤免疫病理有关.
研究的目的:
- 审查胆酸平衡与炎症性皮肤疾病中的免疫功能障碍之间的联系.
- 综合针对治疗创新的胆酸途径的证据.
- 突出胆酸在皮肤免疫调节中的作用.
主要方法:
- 临床和实验数据的汇编.
- 对改变的胆汁酸概况和受体表达的分析.
- 在皮肤病中破坏胆酸信号的审查.
主要成果:
- 在牛皮,亚托皮性皮肤炎 (AD) 和自身免疫性泡性疾病中发现了改变的胆汁酸概况和受体表达.
- 胆汁酸信号传递中障碍会影响皮肤疾病中的炎症和代谢途径.
- 有证据表明,胆酸在某些皮肤疾病中极大地促进免疫病理.
结论:
- 胆酸障碍与免疫介导的皮肤疾病有显著的联系.
- 准胆酸轴是一个有前途的治疗策略.
- 了解胆酸信号对于新的皮肤病治疗至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
100
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
Autoimmune Disorders
313
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
313
Skin Diseases and Disorders
2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
T Cell Types and Functions
615
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
615
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Drugs for Treatment of Ulcerative Colitis in IBD
102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102

